DeviceTalks Podcast Network

In the latest episode of AbbottTalks, Abbott Cardiovascular's leaders, Christopher Piorkowski, MD, DVP and Chief Medical Officer of Electrophysiology, and Dan Kaiser, Divisional VP Product Development, Electrophysiology, delve into the vast landscape of electrophysiology and the comprehensive approach Abbott is taking towards atrial fibrillation (AFib) treatment. The conversation highlights a potentially innovative pulsed field ablation (PFA) technology and Abbott's broader AFib portfolio, showcasing a commitment to revolutionizing cardiac arrhythmia management. While the VoltTM Pulsed Field Ablation System could represent a significant leap forward with its unique capabilities for creating precise and tissue-selective lesions, Piorkowski and Kaiser emphasize the diversity and depth of solutions Abbott is developing. This includes advancements in diagnostic tools, patient monitoring, and a range of therapeutic approaches designed to offer customized and effective treatment pathways for individuals with AFib. By focusing on a holistic view of patient care, they discuss how Abbott aims to improve clinical outcomes through technological innovation and enhance patients' quality of life by making treatments more accessible, reducing procedure times, and addressing the broad spectrum of needs within the electrophysiology community. With ongoing clinical trials and research, Abbott is positioned at the forefront of addressing the unmet needs in AFib management, underlining the company's commitment to continuous innovation and patient-centered care. Thank you to Cretex Medical for sponsoring this episode of AbbottTalks. For more information on how Cretex Medical works with medical device companies, visit www.cretexmedical.com. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders.

Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next.

Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIRTM DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2iTM (implant-to-implant) technology.

The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives.

Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/

Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Marwan Berrada, founder and managing partner of Santa Clara-based T45 Labs about how incubators can start new companies at a time when early-stage funding is scarce. MassDevice Editor Chris Newmarker deliveres his Newmarker’s Newsmakers including GE HealthCare, Zimmer Biomet, Momentis Surgical, Johnson & Johnson MedTech and, of course, the news surrounding HHS. This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.

This MassDevice podcast featuring Covidien's Stacy Enxing Seng was recorded live on June 24th at DeviceTalks Minnesota.